CytoDyn Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
CytoDyn Inc. (CYDY) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $7.24 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-08-31
- CytoDyn Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2026 was $7.24M.
- CytoDyn Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$2.43M.
- CytoDyn Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $10.94M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2026-05-31 | $7.24M 10-K · filed 2026-08-31 |
| 2025-05-31 | -$2.43M 10-K · filed 2026-08-31 |
| 2024-05-31 | $57.00K S-1 · filed 2026-04-22 |
| 2023-05-31 | $10.94M 10-K · filed 2024-08-15 |